InsidersTradesSigma
Track the 한미사이언스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 한미사이언스 has recorded 202 insider filings. Market capitalisation: €2,434.3bn. The latest transaction was reported on 7 July 2026 (Purchase). Among the most active insiders: 임종훈. All data is accessible without an account.
202
Insider Decl.
n/a
Thresholds
n/a
45 ops.
Buy Volume
€281m
34 ops.
Sell Volume
33Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,734 of 29,062 companies
49.8
score / 100
Value41
Quality59
FCF yld0.9%
Earn yld3.8%
EV/EBITDA21.7x
ROE16%
Gross mgn23%
Net mgn8.7%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 July 2026
Declarations202 total
25 of 202 declarations
Acerca de 한미사이언스
Hanmi Science es una empresa surcoreana centrada en el sector de la salud y farmacéutico. Cotiza en el mercado XKRX.